Bullish Analyst View On GW Pharma (GWPH); Ambarella (AMBA) Tops Wall Street Consensus


GW Pharmaceuticals PLC (Nasdaq:GWPH) stock surged $1.24 (or +1.35%) to $93.41 and 343,395 of its shares changed hands on Thursday’s trading session

Brokerage firm Cantor Fitzgerald has initiated coverage on shares of GW Pharma with a Buy rating and a price target of $181.00

The British biopharmaceutical company will present at the Goldman Sachs 37th Annual Global Healthcare Conference on 8 June, 2016

GW Pharmaceuticals, which engages in discovering, developing, and commercializing cannabinoid prescription medicines, has 21.88M Shares Outstanding, Market Capitalization (intraday) of $2.04B and GWPH stock 52-week range is between $35.83 and $133.98 per share



Shares of Ambarella, Inc. (Nasdaq:AMBA) climbed over 8.5% in the extended session Thursday after the company delivered in its financial results quarterly profit and revenue above Wall Street analysts’ expectations

For its first quarter fiscal 2017, Ambarella posted revenue of $57.2 million and non-GAAP net income of $11.4 million or $0.34 per diluted share, down when compared to revenue of $71.0 million and non-GAAP net income of $23.7 million or $0.71 per diluted share in the same quarter the prior year, but exceeding the Capital IQ Consensus Estimate of $0.28 earnings per share on revenues of $56.28 million for the period

AMBA stock closed at $42.48, up $0.94 (or +2.26%) with a total volume of 2,056,174 shares traded during the day

Ambarella, which develops semiconductor processing solutions for video that enable high-definition (HD) video capture, sharing, and display, has 32.84M Shares Outstanding, Market Capitalization (intraday) of $1.40B and AMBA stock one-year range is from $33.39 to $129.19 per share


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://galaxystocks.com/disclaimer/